The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer

PURPOSE: A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian cancer risk in patients from hereditary breast and ovarian families (HBOC), a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pilarski, Robert, Patel, Divya A., Weitzel, Jeffrey, McVeigh, Terri, Dorairaj, Jemima J., Heneghan, Helen M., Miller, Nicola, Weidhaas, Joanne B., Kerin, Michael J., McKenna, Megan, Wu, Xifeng, Hildebrandt, Michelle, Zelterman, Daniel, Sand, Sharon, Shulman, Lee P.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360659/
https://ncbi.nlm.nih.gov/pubmed/22662244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037891
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars